US Patent 7772425 Vitamin D receptor modulators
Patent 7772425 was granted and assigned to Eli Lilly and Company on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+269 characters)
Article
Patent abstract
The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Charles David Jones0
Emilio Enrique Bunel0
Jianliang Lu0
Robert Peter Gajewski0
Sunil Nagpal0
Tianwei Ma0
Ying Kwong Yee0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07772425 Vitamin D receptor modulators US Patent 7772425 Vitamin D receptor modulators
Infobox
Patent Number
07772425
Patent Number
7772425
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07772425 Vitamin D receptor modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07772425
Date of patent
August 10, 2010
Patent application number
12470677
Date Filed
May 22, 2009
Patent primary examiner
Find more entities like US Patent 7772425 Vitamin D receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
